Last reviewed · How we verify
TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction (MIKADO)
This is an observational longitudinal study, prospective, multicenter, performed in metropolitan France, on a representative sample of dermatologists. Data will be collected by physicians during 2 or 3 visits (according to their usual practice), from the patient file, questioning and clinical examination performed during these visits. Data about the patient's perception (satisfaction, perception of local skin reactions, quality of life) will be collected directly by the patient using self-administered questionnaires at inclusion visit, day 7 and 2 months later.
Details
| Lead sponsor | LEO Pharma |
|---|---|
| Status | COMPLETED |
| Enrolment | 1218 |
| Start date | 2014-04 |
| Completion | 2016-02 |
Conditions
- Actinic Keratosis
Interventions
- Ingenol mebutate
Primary outcomes
- Treatment Satisfaction Questionnaire of Medication (TSQM-9) — 2 months after end of treatment
The TSQM-9 scale is a 7-item instrument to be completed by patients. The TSQM-9 domain scores range from 0 to 100 with higher scores representing higher satisfaction on that domaine.